Transaction · 0001231589-26-000001

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 2181.000000 shares for an estimated $1063803.25. Reported holdings after the transaction were 36981.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeJan 02
Trade dateJan 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$496.72
Pre-filing
1mo ago -3.4%1w ago -3.4%1d ago -3.4%
Returns since
7d +0.0%30d +0.0%90d +14.8%180d +10.2%1y +3.2%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-01-02Filed 245 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231589-26-000001
Common Stock
Transaction date
Jan 02, 2026
Filed Jan 02, 2026, 09:30 PM · 0d delay
Shares
2.18k sh
$48.7k per share
Estimated value
-$106M
Computed from shares × price
Holdings after
36.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $480.64 to $481.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $481.66 to $482.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $482.87 to $483.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $484.14 to $485.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $485.39 to $486.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F7

    This transaction was executed in multiple trades at prices ranging from $486.51 to $487.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  8. F8

    This transaction was executed in multiple trades at prices ranging from $487.51 to $488.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  9. F9

    This transaction was executed in multiple trades at prices ranging from $489.06 to $489.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000001
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR